Literature DB >> 20140171

Follow-up endoscopy in gastroenterology: when is it helpful?

Heiko Lübbers1, Reiner Mahlke, Paul Georg Lankisch, Manfred Stolte.   

Abstract

BACKGROUND: The indications for follow-up endoscopy have not been established in all diseases that can be diagnosed by endoscopy.
METHODS: Selective review of the literature and a survey of national guidelines.
RESULTS: In confirmed erosive or non-erosive reflux disease, follow-up endoscopy is indicated only in the presence of complications or Barrett's esophagus. In the case of gastric ulcer or complicated duodenal ulcer, monitoring by endoscopy is mandatory. There is no consensus regarding the indication for follow-up biopsy in confirmed endemic sprue. In an acute episode of confirmed ulcerative colitis, endoscopy is indicated only if the treatment depends on the findings. In confirmed Crohn's disease, this procedure is indicated only in the presence of complications, if the findings are unclear, and before elective intestinal surgery. Those at risk of hereditary colorectal carcinoma without polyposis should undergo colonoscopy annually, starting 5 years before the youngest age of occurrence in their family or at the age of 25 years, whichever comes first.
CONCLUSIONS: With particular reference to further gastrointestinal diseases discussed in the main text, this review unfortunately shows that many of the indications for follow-up endoscopy remain to be ascertained. Controlled studies are needed to establish with sufficient certainty what really helps our patients.

Entities:  

Mesh:

Year:  2010        PMID: 20140171      PMCID: PMC2816788          DOI: 10.3238/aerztebl.2010.0030

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  29 in total

Review 1.  [Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases].

Authors:  E F Stange; S Schreiber; U R Fölsch; A von Herbay; J Schölmerich; J Hoffmann; M Zeitz; W E Fleig; H J Buhr; A J Kroesen; G Moser; H Matthes; G Adler; M Reinshagen; J Stein
Journal:  Z Gastroenterol       Date:  2003-01       Impact factor: 2.000

Review 2.  [Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease].

Authors:  J C Hoffmann; M Zeitz; S C Bischoff; H J Brambs; H P Bruch; H J Buhr; A Dignass; I Fischer; W Fleig; U R Fölsch; K Herrlinger; W Höhne; G Jantschek; B Kaltz; K M Keller; U Knebel; A J Kroesen; W Kruis; H Matthes; G Moser; S Mundt; C Pox; M Reinshagen; A Reissmann; J Riemann; G Rogler; W Schmiegel; J Schölmerich; S Schreiber; O Schwandner; H K Selbmann; E F Stange; M Utzig; C Wittekind
Journal:  Z Gastroenterol       Date:  2004-09       Impact factor: 2.000

Review 3.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

4.  [Short practice guideline for the management of gastroesophageal reflux disease].

Authors:  C Fibbe; J Keller; P Layer
Journal:  Dtsch Med Wochenschr       Date:  2005-08-26       Impact factor: 0.628

5.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 6.  [Update S3-guideline "colorectal cancer" 2008].

Authors:  W Schmiegel; A Reinacher-Schick; D Arnold; U Graeven; V Heinemann; R Porschen; J Riemann; C Rödel; R Sauer; M Wieser; W Schmitt; H-J Schmoll; T Seufferlein; I Kopp; C Pox
Journal:  Z Gastroenterol       Date:  2008-08       Impact factor: 2.000

7.  Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.

Authors:  Thomas Wündisch; Christian Thiede; Andrea Morgner; Astrid Dempfle; Annette Günther; Hongxiang Liu; Hongtao Ye; Ming-Qing Du; Theo D Kim; Ekkehard Bayerdörffer; Manfred Stolte; Andreas Neubauer
Journal:  J Clin Oncol       Date:  2005-10-03       Impact factor: 44.544

8.  Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.

Authors:  P Rozen; M Baratz; F Fefer; T Gilat
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

9.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

10.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  3 in total

1.  Correspondence (letter to the editor): No follow-up endoscopy.

Authors:  Wolfgang Holtmeier
Journal:  Dtsch Arztebl Int       Date:  2010-07-09       Impact factor: 5.594

2.  Correspondence (letter to the editor): Targeted second-line treatment.

Authors:  Jonathan Jantsch; Christian Bogdan
Journal:  Dtsch Arztebl Int       Date:  2010-07-09       Impact factor: 5.594

3.  Role of gastroscopic biopsy of gastric ulcer margins and healed sites in the diagnosis of early gastric cancer: A clinical controlled study of 513 cases.

Authors:  Jing-Jing Wan; Su-Juan Fei; Sheng-Xiang Lv; Shu-Tang Han; Xing-Gang Ma; Dong-Sheng Xu; Hong-Mei Chen; Ju Zhang
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.